MINNEAPOLIS, Dec. 29, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its fourth quarter conference call on Thursday, January 21st at 3:30pm CST. Vascular Solutions' Chief Executive Officer, Howard Root, Chief Financial Officer, James Hennen and VP of Corporate Development, Phil Nalbone, will discuss the company's fourth quarter results. The company will issue an earnings news release after market close on Thursday, January 21st.
This call is being webcast by NASDAQ OMX and can be accessed at Vascular Solutions web site at www.vasc.com. Go to the investor relations portion of the company's website, on the day of the conference call, and click on conference call icon.
For further information about Vascular Solutions, connect to http://www.vasc.com.
CONTACT: Media Contact
Jory Bartels, Legal Project Coordinator
(763) 656-4300


Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Instagram Outage Disrupts Thousands of U.S. Users
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



